Last updated: July 12, 2026

Application No. 19/361,468

Untitled Application

Unknown

Filed

Priority

Oct 21, 2024 — provisional 63/709,864 +4 more

Examiner

DONOGHUE, BRITTNEY ERIN

Art Unit

Tech Center

PharmaEssentia Corporation

Assignee

Pharmaessentia Corporation

OA Round

1 (Non-Final)

This examiner grants 61% of cases after interview

— +54.2% interview lift. A telephonic interview to clarify the technical implementation could significantly improve the outcome.

Based on 95 resolved cases, 2023–2026

Examiner Intelligence

DONOGHUE, BRITTNEY ERIN View full profile →

Grants 61% of resolved cases

Career Allowance Rate

58 granted / 95 resolved

+1.1% vs TC avg

Strong +54% interview lift

Without

With

+54.2%

Interview Lift

resolved cases with interview

Typical timeline

3y 6m

Avg Prosecution

37 currently pending

Career history

137

Total Applications

across all art units

Statute-Specific Performance

§101

0.3%

-39.7% vs TC avg

§103

55.7%

+15.7% vs TC avg

§102

5.1%

-34.9% vs TC avg

§112

9.1%

-30.9% vs TC avg

Black line = Tech Center average estimate • Based on career data from 95 resolved cases

Prosecution Timeline

Jan 08, 2026

Response after Non-Final Action

May 15, 2026

Non-Final Rejection mailed (current)

Precedent Cases

Applications granted by this same examiner with similar technology

16/502,509

Patent 12616735

COMPOSITIONS AND METHODS OF CONTROLLING EXPRESSION OF THERMOGENIN (UCP-1) IN SKELETAL MUSCLES

6y 10m to grant Granted May 05, 2026

17/811,492

Patent 12606598

CHIMERIC KLEBICINS

3y 9m to grant Granted Apr 21, 2026

17/267,331

Patent 12595293

Anti-Follicle Stimulating Hormone Receptor Antibodies

5y 1m to grant Granted Apr 07, 2026

17/806,566

Patent 12528851

IL2-BASED THERAPEUTICS AND METHODS OF USE THEREOF

3y 7m to grant Granted Jan 20, 2026

18/393,420

Patent 12522649

Antibody Purification

2y 0m to grant Granted Jan 13, 2026

Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.

Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2

Expected OA Rounds

61%

Grant Probability

99%

With Interview (+54.2%)

3y 6m

Median Time to Grant

Low

PTA Risk

Based on 95 resolved cases by this examiner. Grant probability derived from career allowance rate.